The financing follows rapid adoption of Notable’s platform across hundreds of sites of care. It has tripled its revenue in the last year and doubled its customer base, Bartel said. 3, 2021 - Notable, a leading intelligent automation company for healthcare, today announced a 100M Series B funding round led by ICONIQ Growth, including participation by Greylock, F-Prime Capital, and Oak HC/FT. Of its more than 800 customers, the company touts over 100 fellow unicorns on that list, including Gusto, Sift and Cockroach Labs. It has already doubled employees in the first six months of 2021. Brazilian venture capital firm active globally that invests in entrepreneurs committed to creating innovative solutions for a new world. It intends to use the new funding to expand into new markets and on sales and marketing. Gem is seeing adoption from large enterprises and is looking at an international expansion in the next year in Western Europe and parts of Asia Pacific. Also, the fact that companies in our portfolio are using Gem is a powerful statement.” “When we look at the pain point, the sourcing that Gem enables its customers to do is something that historically, you would have to sign up on for and wait for people to come to you. “They are stellar, humble and super product-oriented,” he said. Jacobson and his team were doing some work on different products and tools in the marketing suite and thought Gem’s approach for managing interactions with candidates and tracking talent was unique. Matthew Jacobson, general partner at ICONIQ, said he met Gem through an existing relationship with Greylock while the company was going through its Series B. In 2020, the company, which developed an AI-powered natural language processing system that helps doctors reduce their paperwork, landed $20 million in funding.When it comes to diversity in hiring, businesses are their own worst enemy Notable’s Aim Is To Improve AI In Healthcare Sector With a New 100M Investment By plightinternational Notable is the Leading provider of intelligent automation in the healthcare sector, and it wanted to expand more healthcare workers in the industry. ICONIQ Growth invests in Pigment, a modern solution for business planning ICONIQ Growth is proud to announce our partnership with Pinecone, the vector database company providing long-term memory for AI. Robin Healthcare developed an AI-enabled workflow management tool aimed at helping doctors cut down on the paperwork. Snowflake’s CEO reveals his key to accelerating performance. This isn’t the only company focusing on workflow automation. “With its intelligent automation platform, Notable is empowering providers and modernizing patient experiences while reducing the administrative burden and cost of care.” “We are delighted to partner with Notable to accelerate their vision for a future where every healthcare organization can deliver the highest quality personalized care most efficiently,” Caroline Xie, general partner at ICONIQ Growth, said in a statement. The startup plans to use the new cash to help build out its platform to more providers and boost its capabilities. The tool also includes natural language processing capabilities, which let doctors interact with EHR data using vocal or text commands. The team developed AI tools that are able to help doctors navigate through their EHRs, organize documents, and extract and process data, including images, faxes and other EHRs. Specifically, the company’s system is able to help health systems automate patient interactions, this includes scheduling, registration and payment collection. The San Mateo, Calif.-based startup is focused on using automation to help with clinical administration and workflows. This news comes nearly three years after the company announced its $13.5 million Series A round to help further develop its wearable AI assistant. ICONIQ Growth led the round with participation from Greylock, F-Prime Capital and Oak HC/FT. This morning voice-powered doctor’s assistant Notable announced a whopping $100 million Series B funding round.
0 Comments
Leave a Reply. |